NEW YORK (GenomeWeb News) — The Nasdaq Global Market has delisted Tripos’ common stock as of this morning, Tripos said today.
Tripos said the exchange notified the company on Tuesday it would be removed from the exchange for non-compliance with market rules concerning minimum market capitalization and shareholder’s equity.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.